Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JT-1 nasal spray in chronic rhinitis or sinusitis
NCT05331222Terminated
- Sponsor
- Jantar
- Start
- Sep 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of succinylcholine in chronic rhinitis and sinusitis, sponsored by Jantar. Primary endpoint: Change of Sino-Nasal Outcome Test (SNOT) score at 2 weeks. Started Sep 2022; status: terminated.
02
Drugs
succinylcholine
03
Conditions
chronic rhinitissinusitis
Beyond the preview
Go deeper on NCT05331222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05331222.